Literature DB >> 17091175

[Public production of medicines in Brazil: an overview].

Egléubia Andrade de Oliveira1, Maria Eliana Labra, Jorge Bermudez.   

Abstract

This paper analyzes the role of government production of medicines in Brazil, based on a review of the literature and public documents. It begins by examining the main characteristics of the national and international pharmaceutical industry and market dimensions, mainly in the public sector. The government view was examined through Ministry of Health documents. The article concludes with a diagnosis of the state-owned pharmaceutical industry in Brazil, showing a variety of difficulties faced by the laboratories due to political and institutional constraints, management deficiencies, shortage of qualified human resources, and low technological capability.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17091175     DOI: 10.1590/s0102-311x2006001100012

Source DB:  PubMed          Journal:  Cad Saude Publica        ISSN: 0102-311X            Impact factor:   1.632


  2 in total

1.  Public procurement of antineoplastic agents used for treating breast cancer in Brazil between 2013 and 2019.

Authors:  Ranailla Lima Bandeira Dos Santos; Vera Lúcia Edais Pepe; Claudia Garcia Serpa Osorio-de-Castro
Journal:  BMC Cancer       Date:  2022-07-15       Impact factor: 4.638

2.  Can Brazil play a more important role in global tuberculosis drug production? An assessment of current capacity and challenges.

Authors:  Andre Gemal; Joel Keravec; Alexandre Menezes; Anete Trajman
Journal:  BMC Public Health       Date:  2013-03-27       Impact factor: 3.295

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.